{
    "clinical_study": {
        "@rank": "465",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 14, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04322786"
        },
        "id_info": {
            "org_study_id": "ISAC17_205R",
            "nct_id": "NCT04322786"
        },
        "brief_title": "The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",
        "official_title": "The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective? An Analysis Using UK Based Electronic Health Records of 5.6 Million Individuals.",
        "sponsors": {
            "lead_sponsor": {
                "agency": "University College, London",
                "agency_class": "Other"
            }
        },
        "source": "University College, London",
        "oversight_info": {
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No"
        },
        "brief_summary": {
            "textblock": "The study use UK based linked electronic health records from the Clinical Research Datalink\n      (CALIBER) of 5.6 million individuals to conduct a matched case-control study to investigate\n      the incidence of influenza in individuals prescribed ACEI compared to those not prescribed\n      ACEI."
        },
        "overall_status": "Active, not recruiting",
        "start_date": {
            "@type": "Actual",
            "#text": "January 1, 1998"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "March 31, 2020"
        },
        "primary_completion_date": {
            "@type": "Actual",
            "#text": "May 31, 2016"
        },
        "study_type": "Observational",
        "has_expanded_access": "No",
        "study_design_info": {
            "observational_model": "Case-Control",
            "time_perspective": "Prospective"
        },
        "primary_outcome": {
            "measure": "Incidence of influenza",
            "time_frame": "Jan 1st 1998 - May 31st 2016"
        },
        "number_of_groups": "2",
        "enrollment": {
            "@type": "Actual",
            "#text": "1302508"
        },
        "condition": "Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom",
        "arm_group": [
            {
                "arm_group_label": "ACEI user",
                "description": "Individuals with an ACEI prescription in the study population."
            },
            {
                "arm_group_label": "Matched controls",
                "description": "Individuals without an ACEI prescription, and matched to the users by sex and 10-year age categories."
            }
        ],
        "intervention": {
            "intervention_type": "Drug",
            "intervention_name": "ACE inhibitor",
            "description": "Any prescription of ACE inhibitor",
            "arm_group_label": "ACEI user"
        },
        "eligibility": {
            "study_pop": {
                "textblock": "The nested case-control study include cases who had an ACEI prescription during study\n        follow-up. We randomly select one control per case from the study cohort of individuals\n        without any documented ACEI use. Controls are matched to incident AF patients according to\n        sex, age (10-year age strata)."
            },
            "sampling_method": "Non-Probability Sample",
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  We identify individuals aged 18 years or older and registered in the current primary\n             care practice for at least one year.\n\n        Exclusion Criteria:\n\n          -  We exclude individuals with a prior history of influenza and viral pneumonia before\n             study entry."
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "N/A"
        },
        "verification_date": "March 2020",
        "study_first_submitted": "March 23, 2020",
        "study_first_submitted_qc": "March 23, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "March 26, 2020"
        },
        "last_update_submitted": "March 23, 2020",
        "last_update_submitted_qc": "March 23, 2020",
        "last_update_posted": {
            "@type": "Actual",
            "#text": "March 26, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        },
        "condition_browse": {
            "mesh_term": "Respiratory Tract Infections"
        },
        "intervention_browse": {
            "mesh_term": [
                "Enzyme Inhibitors",
                "Angiotensin-Converting Enzyme Inhibitors"
            ]
        }
    }
}